Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FHF complex subunit HOOK interacting protein 2A (FHIP2A) is a protein-coding gene primarily required for the normal functioning of the nervous system. It has been associated with neurological disorders such as syndromic intellectual disability and microcephaly. FHIP2A does not belong to major drug-target classes like enzymes, receptors, transporters, or ion channels, and is not currently considered a therapeutic target. There is no available evidence for interaction with known drugs, biomarker utility, or specific safety concerns related to this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FHF complex subunit HOOK interacting protein 2A (FHIP2A).